Fundraising Fox

RA Capital2023 Investments

3 investments dated 2023 · listed companies and verified rows first · show all

SepternaNASDAQ: SEPNJun 2023

South San Francisco, US

Board seatJake Simson· per SEC Form D

Convergent TherapeuticsApr 2023SEC filingmedium confidence

BiotechCambridge, US

Philip Kantoff(Executive Officer, Director)Neil Bander(Executive Officer, Director)Eric Sullivan(Executive Officer)Alexander Brown(Executive Officer)

BoardTal Zaks(Director)

Board seatJake Simson· per SEC Form D · $99.2M raise · filed May 2023

Nature's ToolboxNov 2023SEC filingmedium confidence

BiotechRio Rancho, US

James Coffin(Executive Officer, Director)Michael Humbert(Executive Officer, Director, Promoter)Alexander Koglin(Executive Officer, Director, Promoter)

BoardDavid Seldin(Director)Edward Liddy(Director)

Board seatPeter Kolchinsky· per SEC Form D · $15M raise · filed May 2025

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.